ACTINIUM PHARMACEUTICALS
Dead / Abandoned — Abandoned — failure to respond (as of 24 Apr 2023)
What this means for you
This application is over — abandoned 11 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97336317
- Mark type
- Stylized text
- Filed
- 29 Mar 2022
- Abandoned
- 11 Apr 2023
- Attorney of record
- Michael E. Dukes
Goods and services
- Class 005 — Pharmaceuticals: medicinal preparations for use in oncology; pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders
Owner
- Actinium Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 24 Apr 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 24 Apr 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 24 Apr 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 10 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Oct 2022 — NON-FINAL ACTION E-MAILED
- 10 Oct 2022 — NON-FINAL ACTION WRITTEN
- 05 Oct 2022 — ASSIGNED TO EXAMINER
- 04 Apr 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Apr 2022 — NEW APPLICATION ENTERED